title: HTR2 receptors in a songbird premotor cortical-like area modulate spectral characteristics of zebra finch song.
abstract: Serotonin [5-hydroxytryptamine (5-HT)] is involved in modulating an array of complex behaviors including learning, depression, and circadian rhythms. Additionally, HTR2 receptors on layer V pyramidal neurons are thought to mediate the actions of psychedelic drugs; the native function of these receptors at this site, however, remains unknown. Previously, we found that activation of HTR2 receptors in the zebra finch forebrain song premotor structure the robust nucleus of the arcopallium (RA) led to increased excitation, and that endogenous 5-HT could roughly double spontaneous firing rate. Here, using in vivo single-unit recordings, we found that direct application of 5-HT to these same RA projection neurons, which are analogous to layer V cortical pyramidal neurons, caused a significant increase in the number of action potentials per song-related burst, and a dramatic decrease in signal-to-noise ratio. Injection of the serotonergic neurotoxin 5,7-dihydroxytryptamine into the third ventricle greatly reduced telencephalic 5-HT and resulted in decreased fundamental frequency of harmonic syllables as well as increased goodness of pitch. Both of these results can be explained by the observed actions of 5-HT on RA projection neurons, and both effects recovered to baseline within 2 weeks following the toxin injection. These results show that 5-HT is involved in modulating spectral properties of song, likely via effects on RA projection neurons, but that adult zebra finches can partially compensate for this deficit within 7 d.
authors: Graduate Program in Neurobiology and Behavior, University of Washington, Seattle, Washington 98195, USA.
authors: William E
authors: WE
authors: Wood
authors: Thomas K
authors: TK
authors: Roseberry
authors: David J
authors: DJ
authors: Perkel
mesh_terms: D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000161:Acoustic Stimulation; D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D015306:Biogenic Monoamines / Q000502:physiology; D004567:Electrodes, Implanted; D055724:Electrophysiological Phenomena / Q000502:physiology; D046369:Finches / Q000502:physiology*; D007276:Injections, Intraventricular; D008297:Male; D009044:Motor Cortex / Q000187:drug effects / Q000502:physiology*; D009434:Neural Pathways / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D017966:Pyramidal Cells / Q000502:physiology; D044348:Receptors, Serotonin, 5-HT2 / Q000187:drug effects / Q000502:physiology*; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000494:pharmacology; D059629:Signal-To-Noise Ratio; D013997:Time Factors; D014828:Vocalization, Animal / Q000187:drug effects / Q000502:physiology*
chemical_list: D015306:Biogenic Monoamines; D044348:Receptors, Serotonin, 5-HT2; D018490:Serotonin Agents; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin